Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs230439 | chr17:3244358 | C/T | 0.000207 | 173 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs230442 | chr17:3245102 | A/C | 0.000207 | 173 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs230465 | chr17:3257339 | G/A | 0.000213 | 172 | 18.1 | 25.92 | 26.88 | KM Plot |
PCPG | rs230467 | chr17:3258491 | C/G | 0.000226 | 172 | 18.1 | 25.87 | 27.2 | KM Plot |
PCPG | rs230472 | chr17:3266022 | A/C | 0.000226 | 172 | 18.1 | 25.43 | 27.27 | KM Plot |
PCPG | rs230481 | chr17:3274549 | T/C | 0.000245 | 170 | 18.1 | 25.92 | 26.88 | KM Plot |
PCPG | rs2305171 | chr2:239097140 | G/A | 2.92E-5 | 170 | 29.43 | 18.2 | 13.22 | KM Plot |
PCPG | rs2306693 | chr12:56680531 | T/C | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs2306694 | chr12:56680636 | C/T | 9.63E-8 | 178 | 0.8 | 27.33 | 25.35 | KM Plot |
PCPG | rs2312957 | chr16:8763218 | C/G | 0 | 178 | 25.47 | 23.53 | 3.17 | KM Plot |
PCPG | rs2312959 | chr16:8763255 | C/A | 0 | 178 | 25.47 | 23.53 | 3.17 | KM Plot |
PCPG | rs2312960 | chr16:8763256 | A/G | 0 | 178 | 25.47 | 23.53 | 3.17 | KM Plot |
PCPG | rs2312961 | chr16:8763431 | C/T | 0 | 178 | 25.47 | 23.53 | 3.17 | KM Plot |
PCPG | rs231403 | chr17:3271586 | A/G | 0.000248 | 170 | 18.1 | 25 | 27.2 | KM Plot |
PCPG | rs231409 | chr17:3252129 | G/A | 0.000226 | 171 | 18.1 | 25.87 | 26.88 | KM Plot |